INS and metabolic dysfunction-associated steatotic liver disease: Results obtained in this study indicate that overweight/obese individuals suffering from hyperlipidemia and NAFLD treated with MHD + NS showed significant improvements in HSIs and γGT biomarker, plasma lipid profile, as well as insulin sensitivity.